SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-025769
Filing Date
2023-07-28
Accepted
2023-07-28 09:02:51
Documents
20
Period of Report
2023-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 91849
2 ex3-1.htm EX-3.1 11974
3 ex3-2.htm EX-3.2 13037
4 ex3-3.htm EX-3.3 13094
5 ex10-1.htm EX-10.1 242534
6 ex10-2.htm EX-10.2 72308
7 ex10-3.htm EX-10.3 68073
8 ex10-4.htm EX-10.4 57612
9 ex10-5.htm EX-10.5 60966
  Complete submission text file 0001493152-23-025769.txt   919066

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE xtnt-20230726.xsd EX-101.SCH 3027
11 XBRL LABEL FILE xtnt-20230726_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE xtnt-20230726_pre.xml EX-101.PRE 22367
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3329
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 231120377
SIC: 2836 Biological Products, (No Diagnostic Substances)